Enhancing the QUAlity and Transparency Of health Research
Use your browser's Back button to return to your search results
|Reporting guideline provided for?
(i.e. exactly what the authors state in the paper)
|Standard definitions and endpoints for neoadjuvant clinical trials in breast cancer|
|Full bibliographic reference||Fumagalli D, Bedard PL, Nahleh Z, Michiels S, Sotiriou C, Loi S, Sparano JA, Ellis M, Hylton N, Zujewski JA, Hudis C, Esserman L, Piccart M; BIG-NABCG collaboration. A common language in neoadjuvant breast cancer clinical trials: proposals for standard definitions and endpoints. Lancet Oncol. 2012;13(6):e240-248.|
|Study design||Clinical trials, Experimental studies|
|Applies to the whole report or to individual sections of the report?||Terminology/definitions|
|Record last updated on||February 11, 2015|
Some reporting guidelines are also available in languages other than English. Find out more in our Translations section.